Synfacts 2025; 21(09): 947
DOI: 10.1055/a-2653-4465
Innovative Drug Discovery and Development

Near-Infrared-Activated Pd@Au Nanorods for Prodrug and Prodye Uncaging

Contributor(s):
Dirk Trauner
,
Kenny Calderon-Godinez
Ortega-Liebana MC *, Travnickova J, Adam C, González-Calderón D, Lorente-Macías Á, Lochenie C, Arenal R, Patton EE, Unciti-Broceta A *. University of Granada, GENYO, Pfizer/University of Granada/Andalusian Regional Government, and Instituto de Investigación Biosanitaria ibs.GRANADA, Spain; University of Edinburgh, UK
Near-Infrared Light-Accelerated Bioorthogonal Drug Uncaging and Photothermal Ablation by Anisotropic Pd@Au Plasmonic Nanorods.

J. Am. Chem. Soc. 2025;
147: 23980-23990
DOI: 10.1021/jacs.5c07261
 

Significance

The authors develop anisotropic palladium-gold (Pd@Au) nanorods that catalyze the uncaging of prodrugs and prodyes under near-infrared (NIR) light. In addition, this study introduces a new masking group, POxOC, allowing effective drug activation in both the presence and absence of NIR stimulation. In vitro and in vivo experiments in zebrafish xenograft models demonstrate efficient drug release, tumor suppression, and minimal toxicity, establishing Pd@Au nanorods as a versatile platform for targeted, light-controlled chemotherapy.


Comment

POxOC, a derivative of POBOC, offers a significant improvement in uncaging performance for chemotherapeutics. Unlike bulky or hydrophobic groups that may hinder drug delivery or require harsh conditions for release, POxOC enables efficient Pd-catalyzed uncaging under biocompatible conditions. Additionally, the discovered thermally induced cleavage by POxOC makes it versatile and effective for in vivo applications.




Publication History

Article published online:
27 August 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany